Roh J, Im M, Kang J, Youn B, Kim W
Anim Cells Syst (Seoul). 2023; 27(1):19-28.
PMID: 36819921
PMC: 9937017.
DOI: 10.1080/19768354.2023.2175497.
Vaghari-Tabari M, Targhazeh N, Moein S, Qujeq D, Alemi F, Majidina M
Cancer Cell Int. 2022; 22(1):146.
PMID: 35410210
PMC: 8996392.
DOI: 10.1186/s12935-022-02557-3.
Jorgensen B, Ro S
Int J Mol Sci. 2022; 23(4).
PMID: 35216281
PMC: 8876324.
DOI: 10.3390/ijms23042166.
Song S, Johnson K, Lujan H, Pradhan S, Sayes C, Taube J
Noncoding RNA. 2021; 7(3).
PMID: 34449670
PMC: 8395754.
DOI: 10.3390/ncrna7030045.
Angius A, Scanu A, Arru C, Muroni M, Rallo V, Deiana G
Int J Mol Sci. 2021; 22(4).
PMID: 33562604
PMC: 7915330.
DOI: 10.3390/ijms22041603.
Targeting deubiquitinating enzyme USP26 by microRNA-203 regulates Snail1's pro-metastatic functions in esophageal cancer.
Li G, Qi H, Dong H, Bai P, Sun M, Liu H
Cancer Cell Int. 2020; 20:355.
PMID: 32760222
PMC: 7393868.
DOI: 10.1186/s12935-020-01441-2.
FOXC2 Promotes Oxaliplatin Resistance by Inducing Epithelial-Mesenchymal Transition via MAPK/ERK Signaling in Colorectal Cancer.
Chen Y, Deng G, Fu Y, Han Y, Guo C, Yin L
Onco Targets Ther. 2020; 13:1625-1635.
PMID: 32110058
PMC: 7041600.
DOI: 10.2147/OTT.S241367.
LINC02595 promotes tumor progression in colorectal cancer by inhibiting miR-203b-3p activity and facilitating BCL2L1 expression.
Yang Z, An Y, Wang N, Dong X, Kang H
J Cell Physiol. 2020; 235(10):7449-7464.
PMID: 32064615
PMC: 7496558.
DOI: 10.1002/jcp.29650.
COTI-2 induces cell apoptosis in pediatric acute lymphoblastic leukemia via upregulation of miR-203.
Guo Y, Zhu X, Sun X
Bioengineered. 2020; 11(1):201-208.
PMID: 32063077
PMC: 7039633.
DOI: 10.1080/21655979.2020.1729927.
LncRNA WT1-AS Downregulates Survivin by Upregulating miR-203 in Papillary Thyroid Carcinoma.
Le F, Luo P, Ouyang Q, Zhong X
Cancer Manag Res. 2020; 12:443-449.
PMID: 32021456
PMC: 6983468.
DOI: 10.2147/CMAR.S232294.
Overexpression of miR-106a enhances oxaliplatin sensitivity of colorectal cancer through regulation of FOXQ1.
Liu Z, Qin Y, Dong S, Chen X, Huo Z, Zhen Z
Oncol Lett. 2020; 19(1):663-670.
PMID: 31897182
PMC: 6924180.
DOI: 10.3892/ol.2019.11151.
Reduced miR-203 predicts metastasis and poor survival in esophageal carcinoma.
He R, Wang J, Ye K, Du J, Chen J, Liu W
Aging (Albany NY). 2019; 11(24):12114-12130.
PMID: 31844033
PMC: 6949080.
DOI: 10.18632/aging.102543.
Long Noncoding RNA NEAT1 Promotes Cell Proliferation And Invasion And Suppresses Apoptosis In Hepatocellular Carcinoma By Regulating miRNA-22-3p/akt2 In Vitro And In Vivo.
Zhou X, Wang X, Zhou Y, Cheng L, Zhang Y, Zhang Y
Onco Targets Ther. 2019; 12:8991-9004.
PMID: 31802908
PMC: 6827517.
DOI: 10.2147/OTT.S224521.
MYC-Induced miR-203b-3p and miR-203a-3p Control Bcl-xL Expression and Paclitaxel Sensitivity in Tumor Cells.
Aakko S, Straume A, Birkeland E, Chen P, Qiao X, Lonning P
Transl Oncol. 2018; 12(1):170-179.
PMID: 30359947
PMC: 6199766.
DOI: 10.1016/j.tranon.2018.10.001.
LncRNA BANCR promotes tumorigenesis and enhances adriamycin resistance in colorectal cancer.
Ma S, Yang D, Liu Y, Wang Y, Lin T, Li Y
Aging (Albany NY). 2018; 10(8):2062-2078.
PMID: 30144787
PMC: 6128424.
DOI: 10.18632/aging.101530.
S100A11 promotes human pancreatic cancer PANC-1 cell proliferation and is involved in the PI3K/AKT signaling pathway.
Xiao M, Li T, Ji Y, Jiang F, Ni W, Zhu J
Oncol Lett. 2018; 15(1):175-182.
PMID: 29375710
PMC: 5766079.
DOI: 10.3892/ol.2017.7295.
MicroRNAs and their role for T stage determination and lymph node metastasis in early colon carcinoma.
Rammer M, Webersinke G, Haitchi-Petnehazy S, Maier E, Hackl H, Charoentong P
Clin Exp Metastasis. 2017; 34(6-7):431-440.
PMID: 29134398
DOI: 10.1007/s10585-017-9863-9.
MiR-200c regulates tumor growth and chemosensitivity to cisplatin in osteosarcoma by targeting AKT2.
Liu Y, Zhu S, Wang X, Deng J, Li W, Zhang P
Sci Rep. 2017; 7(1):13598.
PMID: 29051585
PMC: 5648776.
DOI: 10.1038/s41598-017-14088-3.
miR-19b-3p promotes colon cancer proliferation and oxaliplatin-based chemoresistance by targeting SMAD4: validation by bioinformatics and experimental analyses.
Jiang T, Ye L, Han Z, Liu Y, Yang Y, Peng Z
J Exp Clin Cancer Res. 2017; 36(1):131.
PMID: 28938919
PMC: 5610468.
DOI: 10.1186/s13046-017-0602-5.
miR-203 as a novel biomarker for the diagnosis and prognosis of colorectal cancer: a systematic review and meta-analysis.
Ye H, Hao H, Wang J, Chen R, Huang Z
Onco Targets Ther. 2017; 10:3685-3696.
PMID: 28769572
PMC: 5533489.
DOI: 10.2147/OTT.S134252.